Julie A. Means-Powell, M.D., MSCI
Assistant Professor of Medicine
- Clinical Trials Information
- Clinical Trials: 1-800-811-8480
- Online Self-Referral Form
- Other Telephone NumbersDivision of Hematology/Oncology
Vanderbilt Breast Center One Hundred Oaks
615-322-2064; Referring Physicians: 615-343-9283
- FaxesDivision of Hematology/Oncology Fax
Vanderbilt Breast Center One Hundred Oaks Fax
Dr. Means-Powell joined the Faculty at Vanderbilt Ingram cancer Center in July 2004 as an Assistant Professor in the Division of Hematology/Oncology. She received her Doctorate of Medicine degree at East Carolina School of Medicine, in Greenville, North Carolina in 1997.
Read more ....
Dr. Means-Powell joined the Faculty at Vanderbilt Ingram cancer Center in July 2004 as an Assistant Professor in the Division of Hematology/Oncology. She received her Doctorate of Medicine degree at East Carolina School of Medicine, in Greenville, North Carolina in 1997. She completed her Internal Medicine Residency in June of 2000 at Vanderbilt Medical Center in Nashville, Tennessee, where she also did her Hematology/Oncology Fellowship from 2000 through 2003. She was awarded the Shining Star award in 2002 for academic excellence and outstanding initiative in the Division of Hematology/Oncology at Vanderbilt University Medical Center, while a clinical fellow. She completed her Master of Science in Clinical Investigation in May of 2004.
Dr. Means-Powell has been an important member of our breast cancer team over the last 10 years. She is very dedicated to her patients and highly motivated to improve the treatments options available for breast cancer patients. She strives to treat patients with compassion and respect while offering them the most advanced cancer treatments and opportunities to participate in clinical trials. Her focus is always on the patient and helping them and their family members feel they are receiving the highest level of comprehensive cancer care. She is active in the Eastern Cooperative Oncology Group and has served as the Institutional Principle Investigator of multiple cooperative group and Industry sponsored trials in breast cancer. She has been the principle investigator for the A Phase I Dose Escalation Trial of RO4929097 administered in Combination with Exemestane in Pre- and Postmenopausal Patients with ER + Metastatic Breast Cancer. She is also interested in seeing patients at increased risk for the development of breast cancer to discuss early detection methods and risk reduction strategies.
- 1/87-8/91, Bachelor of Arts, Major Psychology, Texas Tech University, Lubbock, TX
- 8/92-5/96, Doctor of Medicine, East Carolina University School of Medicine, Greenville, NC
- 7/03-5/04, Masters of Science Clinical Investigation, Vanderbilt University Medical Center, Nashville, TN